跳至主要内容
临床试验/NCT06385717
NCT06385717招募中不适用

Multicenter Cohort Study of Chemo-radiotherapy After Endoscopic Submucosal Dissection for High-risk Early-stage Esophageal Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
2
主要终点
Incidence of toxic events

研究概览

简要总结

This multicenter, prospective observational cohort study has the potential to optimize individualized chemoradiotherapy regimen for early-stage esophageal cancer patients who have received endoscopic submucosal dissection.

详细描述

Our study can further improve the local-regional lymph nodes control rate and alleviate the toxicity of chemoradiotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Esophageal cancer patients who are pathologically confirmed as pT1a-MM stage or pT1b stage after endoscopic submucosal dissection;
  • No definite contraindications for chemo-radiotherapy;
  • Informed consent has been signed;
  • Refused surgery after endoscopic submucosal dissection.

排除标准

  • Severe heart, brain, lung disease or renal dysfunction;
  • Previous history of other malignancies;
  • Prior radiation or chemotherapy
  • Researchers consider it inappropriate to participate in this experiment

结局指标

主要结局

Incidence of toxic events

时间窗: 2026.2

esophageal stenosis, radiation pneumonitis, etc

次要结局

  • 3-year local-regional recurrence free survival(2029.1)
  • 3-year overall survival(2029.1)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Multicenter Cohort Study of ESD and... | 临床试验